Oscar Health, Inc.
OSCR · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.17 | 0.13 | 0.09 | -0.03 |
| FCF Yield | 29.41% | -14.68% | 67.22% | -14.78% |
| EV / EBITDA | 22.43 | -2.15 | 1.29 | -0.55 |
| Quality | ||||
| ROIC | 1.57% | -29.06% | -48.27% | -27.69% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 37.45 | 1.01 | -0.62 | 0.32 |
| Growth | ||||
| Revenue 3-Year CAGR | 30.54% | 45.05% | 91.26% | 51.38% |
| Free Cash Flow Growth | 419.17% | -184.74% | 269.21% | -199.48% |
| Safety | ||||
| Net Debt / EBITDA | -13.75 | 7.41 | 2.20 | 2.00 |
| Interest Coverage | 1.41 | -10.86 | -26.97 | -120.89 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 12.56 | 12.53 | 4.41 | 34.03 |